Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Infusense
company
About
Infusense is a platform biosensor to measure propofol levels in patients undergoing anesthesia and sedation.
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $253.59K
- Industries
- Biotechnology,Health Care
- Founded date
- Jan 1, 2009
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$253.59K
Infusense has raised a total of
$253.59K
in funding over 2 rounds. Their latest funding was raised on
Aug 15, 2021 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 15, 2021 | Grant | $253.59K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Infusense is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
